BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/21/2025 7:30:37 AM | Browse: 40 | Download: 0
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Clinical Trials Study |
Article Title |
Medium-to-long term outcomes of bioresorbable scaffold treatment in patients with acute coronary syndrome
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jun Li, Xin-Rui Li, Mo-Wei Kong and Jie Zhang |
Funding Agency and Grant Number |
|
Corresponding Author |
Jie Zhang, MD, Department of Cardiology, Ren’an Hospital, No. 9 Weixin Road, Industrial Park, Zhaoyang District, Zhaotong 657000, Yunnan Province, China. 443544378@qq.com |
Key Words |
Bioresorbable scaffolds; Acute coronary syndrome; Percutaneous coronary intervention; C-reactive protein; Drug-eluting stents |
Core Tip |
This study aimed to investigate the safety and effectiveness of bioresorbable scaffolds (BRS) compared to drug-eluting stents (DES) in patients with intermediate to low-risk acute coronary syndrome. A total of 128 patients were included in the study, with 87 receiving BRS and 114 receiving DES. The patients were followed up for a maximum of 3 years to assess the occurrence of cardiac events and complications. The results showed that the time to reach the composite endpoint of cardiac events was earlier in the BRS group compared to the DES group, although the final number did not differ significantly. BRS demonstrated better compatibility than DES. These findings suggest that BRS may be a viable alternative to DES in patients with intermediate to low-risk acute coronary syndrome, but further research is needed to address the observed complications. |
Citation |
Li J, Li XR, Kong MW, Zhang J. Medium-to-long term outcomes of bioresorbable scaffold treatment in patients with acute coronary syndrome. World J Cardiol 2025; In press |
 |
Received |
|
2025-05-13 09:02 |
 |
Peer-Review Started |
|
2025-05-13 09:02 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-06-25 03:02 |
 |
Revised |
|
2025-07-02 08:26 |
 |
Second Decision |
|
2025-10-20 03:00 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-10-21 07:30 |
 |
Articles in Press |
|
2025-10-21 07:30 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1949-8462 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345